As of this week, consumers can order Dexcom Inc.’s Stelo continuous glucose monitor (CGM) online without a prescription, making it the first to hit the market. Dexcom will have competition soon, ...

We first reported on Stelo at CES 2024, and 8 months on, it’s now available in the US without a prescription. Unlike the company’s existing G7 CGM, Stelo is designed for adults 18+ who are not on ...

On March 5, 2024, the US Food and Drug Administration (FDA) granted clearance to market the first over-the-counter (OTC) continuous glucose monitor (CGM). Dexcom’s Stelo Glucose Biosensor System ...

A little over a year ago, I was on my way to a conference. My bags were packed, the Uber was on its way, but there was one ...

In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...

The launch of the first over-the-counter glucose sensors last year has raised a debate about who benefits from these devices. The Food and Drug Administration cleared devices made by Dexcom and Abbott ...

The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of every four healthcare dollars spent in the country. The first step in ...

The U.S. Food and Drug Administration (FDA) has cleared the first continuous glucose monitors (CGMs) for over-the-counter sale—a major win for health freedom and common sense. "Giving more individuals ...

Four years ago, my life changed after a heart attack at the age of 33. While a quick coronary angioplasty meant my heart was mostly fine, the tests conducted at the same time revealed a bigger chronic ...